MedKoo Cat#: 145979 | Name: Piperidenafil

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Piperidenafil is a synthetic compound that acts as a selective inhibitor of phosphodiesterase type 5 (PDE5), similar to other drugs in this class, such as sildenafil (Viagra). Its primary application is in the treatment of erectile dysfunction (ED) by enhancing the effects of nitric oxide, which promotes smooth muscle relaxation and improves blood flow to the penis. The mechanism of piperidenafil involves inhibiting PDE5, which normally breaks down cyclic GMP, thus increasing cyclic GMP levels and facilitating vasodilation. This leads to improved erectile function and is beneficial for men with ED, offering a potential therapeutic alternative to other PDE5 inhibitors.

Chemical Structure

Piperidenafil
Piperidenafil
CAS#224788-34-5

Theoretical Analysis

MedKoo Cat#: 145979

Name: Piperidenafil

CAS#: 224788-34-5

Chemical Formula: C22H29N5O4S

Exact Mass: 459.1900

Molecular Weight: 459.57

Elemental Analysis: C, 57.50; H, 6.36; N, 15.24; O, 13.93; S, 6.98

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Piperidenafil; Piperadenafil;
IUPAC/Chemical Name
2-(2-ethoxy-5-(piperidin-1-ylsulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one
InChi Key
QAYHPAMSDMZXJB-UHFFFAOYSA-N
InChi Code
1S/C22H29N5O4S/c1-4-9-19-23-15(3)20-22(28)24-21(25-27(19)20)17-14-16(10-11-18(17)31-5-2)32(29,30)26-12-7-6-8-13-26/h10-11,14H,4-9,12-13H2,1-3H3,(H,24,25,28)
SMILES Code
CCCC1=NC(C)=C2N1NC(=NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCCCC4
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 459.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Lin YP, Lee YL, Hung CY, Chang CF, Chen Y. Detection of adulterated drugs in traditional Chinese medicine and dietary supplements using hydrogen as a carrier gas. PLoS One. 2018 Oct 10;13(10):e0205371. doi: 10.1371/journal.pone.0205371. PMID: 30304050; PMCID: PMC6179279. 2: Reepmeyer JC, Woodruff JT. Use of liquid chromatography-mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a "natural" herbal dietary supplement. J Chromatogr A. 2006 Aug 25;1125(1):67-75. doi: 10.1016/j.chroma.2006.05.018. Epub 2006 Jun 5. PMID: 16750214. 3: Poon WT, Lam YH, Lai CK, Chan AY, Mak TW. Analogues of erectile dysfunction drugs: an under-recognised threat. Hong Kong Med J. 2007 Oct;13(5):359-63. PMID: 17914141. 4: Gryniewicz CM, Reepmeyer JC, Kauffman JF, Buhse LF. Detection of undeclared erectile dysfunction drugs and analogues in dietary supplements by ion mobility spectrometry. J Pharm Biomed Anal. 2009 Apr 5;49(3):601-6. doi: 10.1016/j.jpba.2008.12.002. Epub 2008 Dec 11. PMID: 19150190.